QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, announced its participation in the upcoming Baird 2025 Global Healthcare Conference. The company's management team will engage in a fireside chat on September 10, 2025, at 3:10 p.m. ET.
Investors and interested parties can access the live webcast and replay through QuidelOrtho's investor relations website. The company specializes in diagnostic solutions for point-of-care settings, clinical laboratories, and transfusion medicine.
QuidelOrtho (NASDAQ: QDEL), fornitore mondiale di tecnologie diagnostiche in vitro, ha annunciato la sua partecipazione al Baird 2025 Global Healthcare Conference. Il team di dirigenti dell'azienda parteciper脿 a una fireside chat il 10 settembre 2025 alle 15:10 ET.
Investitori e interessati potranno seguire la diretta e la replica tramite il sito web per gli investitori di QuidelOrtho. L'azienda 猫 specializzata in soluzioni diagnostiche per il punto di cura, i laboratori clinici e la medicina trasfusionale.
QuidelOrtho (NASDAQ: QDEL), proveedor global de tecnolog铆as de diagn贸stico in vitro, anunci贸 su participaci贸n en la Baird 2025 Global Healthcare Conference. El equipo directivo de la compa帽铆a participar谩 en una charla informal el 10 de septiembre de 2025 a las 3:10 p.m. ET.
Los inversores y dem谩s interesados podr谩n acceder a la transmisi贸n en vivo y a la repetici贸n a trav茅s del sitio web de relaciones con inversores de QuidelOrtho. La compa帽铆a se especializa en soluciones diagn贸sticas para entornos de atenci贸n en el punto de atenci贸n, laboratorios cl铆nicos y medicina transfusional.
QuidelOrtho (NASDAQ: QDEL), 觳挫櫢 歆勲嫧 旮办垹鞚� 旮�搿滊矊 瓿店笁鞐呾泊臧� 雼り皜鞓る姅 Baird 2025 Global Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓 瓴届榿歆勳潃 2025雲� 9鞗� 10鞚� 鞓ろ泟 3鞁� 10攵�(霃欕秬 響滌鞁�)鞐� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞐� 彀胳棳頃╇媹雼�.
韴瀽鞛� 氚� 甏�鞁� 鞛堧姅 靷瀸霌れ潃 QuidelOrtho 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 靸濎瓿� 氚� 雼れ嫓 氤搓赴毳� 鞚挫毄頃� 靾� 鞛堨姷雼堧嫟. 須岇偓電� 順勳灔(point-of-care) 歆勲嫧, 鞛勳儊 鞁ろ棙鞁� 氚� 靾橅槇 鞚橅暀鞚� 鞙勴暅 歆勲嫧 靻旊（靺橃潉 鞝勲鞙茧 頃╇媹雼�.
QuidelOrtho (NASDAQ: QDEL), fournisseur mondial de technologies de diagnostic in vitro, a annonc茅 sa participation 脿 la Baird 2025 Global Healthcare Conference. L'茅quipe dirigeante de la soci茅t茅 prendra part 脿 une discussion informelle le 10 septembre 2025 脿 15h10 ET.
Les investisseurs et les personnes int茅ress茅es peuvent acc茅der 脿 la retransmission en direct et au replay via le site investisseurs de QuidelOrtho. L'entreprise est sp茅cialis茅e dans les solutions diagnostiques pour les points de soins, les laboratoires cliniques et la m茅decine transfusionnelle.
QuidelOrtho (NASDAQ: QDEL), ein weltweit t盲tiger Anbieter von In-vitro-Diagnostiktechnologien, k眉ndigte seine Teilnahme an der Baird 2025 Global Healthcare Conference an. Das Managementteam des Unternehmens wird am 10. September 2025 um 15:10 Uhr ET an einem Fireside-Chat teilnehmen.
Investoren und Interessierte k枚nnen das Live-Webcast und die Aufzeichnung 眉ber die Investor-Relations-Website von QuidelOrtho abrufen. Das Unternehmen ist auf diagnostische L枚sungen f眉r Point-of-Care, klinische Labore und Transfusionsmedizin spezialisiert.
- None.
- None.
Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at .
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent in vitro diagnostics solutions that transform data into understanding and action for more people in more places every day.听
By offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, QuidelOrtho brings fast, accurate and reliable diagnostics when and where they are needed 鈥� from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
[email protected]听
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
[email protected]听
View original content to download multimedia:
SOURCE QuidelOrtho Corporation
FAQ
When is QuidelOrtho (QDEL) presenting at the Baird 2025 Global Healthcare Conference?
How can investors access QuidelOrtho's (QDEL) presentation at the Baird conference?
What type of products does QuidelOrtho (QDEL) specialize in?
What format will QuidelOrtho's (QDEL) presentation take at the Baird Healthcare Conference?
